Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CSC/HTS-based combination therapy for recurrent glioblastoma
NCT02654964Phase 1Completed
- Sponsor
- Swedish Health Services
- Start
- Dec 2015
- Primary completion
- Nov 2021
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in glioblastoma multiforme (GBM), sponsored by Swedish Health Services. Primary endpoints: Tumor size at 1 year, Progression-Free Survival at 1 year and 2 more. Started Dec 2015; status: completed.
02
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT02654964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02654964.